Antithrombosis Trials: Should We Test Therapeutic Heparin Adjusted Based on Activated Partial Thromboplastin Time in Septic Shock?*

Critical Care Medicine - United States
doi 10.1097/ccm.0b013e31819d2bb4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search